***********************************
Brakke Consulting’s
Animal Health News & Notes for February 21, 2025
Copyright © Brakke Consulting
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
Brakke Consulting News
Cancer in Dogs and Cats report – last week for pre-order discount
Brakke Consulting 2025 Industry Overview at WVC
Earnings News
Freshpet
PetVivo
Pilgrim’s Pride
Trupanion
Other News
Anivive Lifesciences
Care TopCo
Colgate-Palmolive
Creative Science
ECO Animal Health Group
Elanco (Zenrelia)
Elanco (Pet Protect)
Enso Discoveries
Epica Animal Health
Fonterra
Hill’s (APOP)
Hill’s (Prime100)
Imaginalis
Mars
PetVivo Holdings
Pure Nutritional Products
Simply Done Tech Solutions
Sunzen Group
Tapir
Veterinary Pharmaceutical Solutions
Vetirus Pharmaceuticals
VetStem
VetVerifi
ZoaDx
Zoetis
*****************************************
Brakke Consulting
2025 Cancer in Dogs and Cats – last week for pre-order discount
Did you know that cancer is the #1 cause of death in adult dogs? It’s also a leading health concern of dog owners. So how is cancer addressed by the veterinary profession, and what kind of market is there for veterinary cancer therapies?
Brakke Consulting’s new 2025 Cancer in Dogs and Cats report includes information on the incidence, diagnosis, and treatment of the common veterinary cancers. It covers currently approved veterinary therapies and those in development, as well as estimates of the numbers of pets treated.
The study includes a survey of 300 general veterinary practitioners about incidence of cancer and frequency of treatment; as well as a survey of 1,000 pet owners to determine what they are willing to pay to treat a pet with cancer.
The report is available for pre-order for $7,995 until February 28, and $8,500 thereafter. The report will be published in March. For more information, please contact Dr. Lynn Fondon at info@brakkeconsulting.com .
*********************************************
EARNINGS NEWS RELEASES
- Trupanion, Inc. announced financial results for the full year 2024. Total revenue was $1,286 million, an increase of 16% compared to 2023. Net loss was $(9.6) million, compared to a net loss of $(44.7) million in 2023. (company press release)
- Freshpet, Inc. reported financial results for its full year 2024. Net sales were $975 million, an increase of 27%. Net income was $46.9 million, compared to the prior year net loss of $(33.6) million. (seekingalpha)
- PetVivo Holdings, Inc. reported results for its fiscal third quarter ended December 31, 2024. Revenues totaled $583,000, a decline of 2% from the same year ago period. Net loss totaled $(1.76) million as compared to a net loss of $(1.75) million in the same year-ago quarter. (net)
- Pilgrim’s Pride , a leading global food company, reported financial results for its fiscal 2024 year. Net sales were $17.9 billion, a 3.0% increase from 2023, with operating income rising 188.4% to $1.506 billion. (Feedstuffs)
**************************************
Brakke Consulting
Brakke Consulting 2025 Industry Overview
Presented at WVC: Monday, March 3rd , 2-4 pm, Four Seasons Ballroom 4
How did the top animal health companies perform in 2024? What critical issues and new products will impact industry performance in 2025? Answers to these questions and more will be covered at Brakke Consulting’s annual Industry Overview at the VMX and WVC conferences next year. Key topics and presenters include:
- Industry and Top Global Company 2024 Performance, presented by Bob Jones
- Pets and Vets: Companion Animal Practice in Transition, presented by John Volk
- Parasiticides in Pets – Back to the Future, presented by Darrell Klug
- Regenerative Medicine ─ Future Game-Changing Therapies, presented by Mike McGinley
Also, again at both events, you will be able to hear directly from a panel of top leaders in the animal health industry. Moderated by Paul Casady, the topic for the panel will be “Opportunities and Challenges in 2025.” The panelists for WVC are Jesper Nordengaard, CEO, Dechra; and Tammi Lesser, Sr. VP, Sales & Marketing, Antech.
This information-packed 2-hour session will be especially valuable for executive leadership, sales and marketing, strategy, and finance managers and for decision makers in the animal health industry.
Click here to register for WVC
You can also email Amanda McDavid or call at 336-396-3916. Registration cost is $399; there are discounts for multiple attendees from the same company. We look forward to seeing you there!
***********************************
COMPANY NEWS RELEASES
- Zoetis announced that the USDA) Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labelled for use in chickens. (company press release)
- The FDA recently issued a Warning Letter to Elanco related to statements in Zenrelia (ilunocitinib tablets) promotional materials. This letter is not related to the in-market product use experience, and Elanco does not expect the adjustments to the promotional materials to have a material impact on Zenrelia revenue. For full prescribing information for Zenrelia, including the boxed warning, click here. (company press release)
- Elanco Animal Health Incorporated announced the launch of Pet Protect, a line of veterinarian-formulated supplements for dogs and cats. Pet Protect offers a full line of supplements, including products promoting healthy skin, helping to support situational stress, and supporting joint health and immune function. (company press release)
- Hill’s Pet Nutrition and the Association for Pet Obesity Prevention (APOP) announced they are combining their expertise in pet nutrition, veterinary medicine and pet parent education to empower and encourage a supportive environment for achieving and maintaining healthy weight in pets. (prnewswire)
- Mars announced a new program through its partnership with Fonterra, one of the world’s largest dairy suppliers, to create the Farmer Forward Program. Backed by a $27 million, five-year investment, the Farmer Forward Program aims to empower dairy farmers to embrace climate-smart agriculture practices as Mars strives to cut greenhouse gas emissions 50% by 2030 against a 2015 baseline. (Feedstuffs)
- Anivive Lifesciences announced that the American Veterinary Medical Association and the Feline Veterinary Medical Association have nominated GC376 for inclusion on the FDA’s List of Bulk Drug Substances (BDS) for Compounding Office Stock Drugs for Use in Nonfood-Producing Animals. If the nomination is accepted by the FDA, Anivive would be able to sell GC376 BDS to compounding pharmacies, allowing them to make and sell the compounded medicine to veterinarians, improving the availability of FIP treatments for cats. (com)
- Vetirus Pharmaceuticals announced its acquisition of Enso Discoveries, LLC, a biotech company specializing in regenerative medicine and maker of Rebound PRP and Rebound PRF. Financial terms were not disclosed. (company press release)
- PetVivo Holdings, Inc. announced it has entered into an Exclusive License and Supply Agreement with VetStem, Inc. to commercialize VetStem’s allogeneic orthobiologic products, PrecisePRP canine and PrecisePRP equine. PrecisePRP is a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians. (globenewswire)
- Veterinary Pharmaceutical Solutions announced the launch of Mendicin and Healicin ABF wound care products for swine. Mendicin is a compounded patent-pending prescription antibiotic ointment containing Bacitracin and Neomycin; Healicin is a non-antibiotic spray available without a veterinarian’s prescription. (Feedstuffs)
- Epica Animal Health announced it is re-branding as Imaginalis. The company also announced the formal launch of the DelphiVet veterinary-specific surgical navigator at the 2025 Western Veterinary Conference (WVC). (company press release)
- VetVerifi announced the successful closure of its $2.8 million seed funding round. The round was led by Las Olas Venture Capital (LOVC), with participation from Roo Capital and Market Square Ventures. (company press release)
- ZoaDx, a newly launched clinical research organization, is dedicated to advancing animal health and agricultural sustainability through expert clinical research, tailored regulatory solutions, and quality assurance consulting. ZoaDx maintains a strategic affiliation with CovarsaDx, a leading contract research organization specializing in IVD and medical device studies, to bridge the gap between human and animal health research. (prnewswire)
- Simply Done Tech Solutions, offering veterinary marketing and technology solutions, announced its rebranding as Tapir. (com)
- Creative Science announced that, through its microchip and recovery brand, BuddyID, it is offering free lifetime registration for all pets with Save This Life microchips, following the recent shutdown of the Save This Life pet registry. (company press release)
- AUSTRALIA Colgate-Palmolive Company announced that it has agreed to acquire Care TopCo Pty Ltd, owner of the Prime100 pet food brand. Prime100 is a fresh pet food brand offering both refrigerated and shelf stable products, sold to pet specialty and other retailers in Australia. This acquisition provides the Company’s Hill’s Pet Nutrition division with an entry into the fresh pet food category. Financial terms were not disclosed. (Yahoo Finance)
- SOUTH AFRICA ECO Animal Health Group plc announced the disposal of certain non-core product lines to its distribution partner in South Africa. The ECOmectin licenses disposed of in the transaction are for use in sheep and cattle and include a range of anti-parasitic treatments and have for some time been non-core to ECO. All licenses are specific to Southern Africa (South Africa, Botswana, Namibia and Zambia). Consideration of GBP 491,000 ($619,500) was received in lieu of pro-rata past and future royalties; nil royalties were recorded in the year ended March 31 2024. (company press release)
- MALAYSIA Sunzen Group Bhd announced it has sold its animal health subsidiaries, Sunzen Corp Sdn Bhd (SCSB) and Sunzen Lifesciences Sdn Bhd (SLSB), to Pure Nutritional Products Sdn Bhd for RM17.3 million ($3.9 million). SCSB and SLSB, which have been engaged in biotechnology research and development and animal health products, reported combined losses of RM(4.1) million for the financial period ended June 30, 2024. (com/my)
*********************************************
ANIMAL HEALTH STOCK PRICE TRACKER
***********************************
ANIMAL HEALTH NEWS
- US – DRUG REGULATION The American Veterinary Medical Association expressed support for the reintroduction of the Combating Illicit Xylazine Act in both the House and Senate. The legislation would categorize xylazine as a Schedule III controlled substance while maintaining its availability to veterinarians. (Vet Advantage)
- US – TELEMEDICINE Arkansas Governor Sarah Huckabee Sanders signed into law two veterinary telemedicine bills. Act 18 authorizes veterinary telemedicine in the state, and Act 19 allows veterinary technicians to go on location for emergency calls without a veterinarian. (Vet Advantage)
************************************
BRAKKE CONSULTING VIEWPOINT
INNOVATION and PARTNERSHIPS: the key message at Animal Health and Nutrition Innovation Conference, London
Attending the recent AHNTI conference in London, it was great to catch up with old friends, but also to meet new innovators. The overall spirit was very positive in both the pet and food animal spaces.
This year’s major topic was Artificial Intelligence (AI) and several speakers commented on the potential benefits this could bring to our industry.
What became very apparent, is that several leading companies are looking more and more towards the innovative entrepreneur, to bring growth to their companies via partnerships. This method definitely cuts down the time to market as they simply screen proven concepts that require investment getting the product or service or technology to market.
Navigating the early development phase and especially funding for the early startup, was flagged as a challenging area, stifling growth.
Another trend observed, was the increased interest from Human Biopharma companies, looking at entering the pet space with either focused therapeutic vaccines or monoclonal antibody technologies. These companies have done their homework and were well aware of the different challenges and different pricing structures in our industry.
Brakke consulting had several interactions with clients and potential clients and we will be assisting them in several areas, ranging from finding potential partners, testing the market to gain clear understanding of where and how their product offering will fit into the USA market as well as finding target areas to launch products into. Yet another partnership to drive value from an innovator!
Lourens Havenga
Paul Casady
***********************************
YOUR VIEW
Last week, we asked how much you planned to spend on your pets for Valentine’s Day. Only 17% said you planned to buy something: 5% of you each said less than $5, $10 – 20, or more than $20 (lucky dog/cat!), and 2% said $5-10. 83% of you said you were spending nothing.
This week
The state of Arkansas recently enacted laws to authorize veterinary telemedicine. Telemedicine is still very much a work in progress in veterinary medicine, ranging from states that prohibit it entirely to those that specifically allow it. What are your thoughts?
English (United States) 
Portuguese